Investments (Details Narrative) - USD ($)									1 Months Ended	9 Months Ended	12 Months Ended
	Jul. 22, 2021	Apr. 01, 2021	Mar. 18, 2021	Mar. 18, 2021	Mar. 15, 2021	Dec. 30, 2020	Dec. 19, 2020	Sep. 10, 2020	Sep. 30, 2021	Sep. 30, 2021	Dec. 31, 2023	Dec. 31, 2022	Mar. 31, 2022	Dec. 31, 2021
Marketable securities											$ 10,000,000.0
Unrealized gain loss on investments											(17,325,000)	$ (17,976,000)
Investments												4,341,000
Issuance of common stock, net of expenses											268,000	17,405,000
Proceeds from Issuance of common stock												1,519,000
Vivacitas Agreement [Member]
Stock options exercised	1,000,000
Stock options exercised price	$ 1,000,000
Investment owned at cost												$ 4,100,000		$ 4,035,000
Investment ownership percentage												100.00%	100.00%
Common Stock [Member]
Issuance of common stock, net of expenses											$ 1	$ 43,000
Issuance of common stock, net of expenses, shares											62,354	2,146,200
BMI Capital International LLC [Member]
Issuance of common stock, net of expenses								$ 100,000
Investments equity method											$ 34,000	$ 20,000
Impact Oncology PTE Ltd. [Member]
Owners shares			2,480,000	2,480,000
Options to purchase additional shares			250,000
Business combination consideration transferred			$ 2,480,000	$ 2,480,000
Stemtech Corporation [Member] | Securities Purchase Agreement [Member]
Investments									$ 1,400,000	$ 1,400,000
Business combination consideration transferred										1,400,000
Convertible promissory note									$ 1,400,000	1,400,000
Origination fee										$ 500,000
Maturity date										Sep. 09, 2024
Interest rate									10.00%	10.00%
Stockholders equity										154,173
Warrant outstanding											0	0
Note payable											$ 44,000	$ 39,000
DSS Securities, Inc. [Member]
Equity position percentage								14.90%
BMI Capital International LLC [Member]
Equity position percentage								24.90%
BMI Capital International LLC [Member] | Minimum [Member]
Equity position percentage								20.00%
BioMed Technologies Asia Pacific Holdings Limited [Member]
Equity position percentage							4.99%
Issuance of common stock, net of expenses							$ 632,000
Issuance of common stock, net of expenses, shares							525
Vivacitas Oncology Inc [Member] | Vivacitas Agreement [Member]
Equity position percentage												16.00%
Moji Life LLC [Member] | Membership Unit Purchase Agreement [Member]
Equity position percentage									30.75%	30.75%
Payments to Acquire Equity Method Investments									$ 1,537,000
Alset International Limited [Member]
Owners shares											127,179,291
Outstanding share percentage											4.00%
Marketable securities											$ 3,269,000	$ 3,319,000
Unrealized gain loss on investments											50,000	1,590,000
Alset International Limited [Member] | Executive Director and Chief Executive Officer [Member]
Unrealized gain loss on investments											50,000	1,590,000
West Park Capital, Inc [Member]
Debt instrument convertible threshold percentage of stock price trigger						7.50%
Investments											$ 500,000	$ 500,000
DSS Securities, Inc. [Member]
Issuance of common stock, net of expenses								$ 100,000
Outstanding membership interest								10.00%
Vivacitas Oncology Inc [Member]
Options to purchase additional shares					1,500,000
Shares issued, price per share					$ 1.00
Additional price per share					$ 1.00
Proceeds from Issuance of common stock					$ 500,000
Business combination consideration transferred		$ 120,000
Sale of stock, description		the Company entered into an additional stock purchase agreement with Vivacitas (“Vivacitas Agreement #2”), whereas Vivacities wished to employ the service of the Chief Business Officer of Impact Biomedical, and in return for the services of this individual, Vivacitas shall issue to the Company, the aggregate purchase price for the Class A Common Shares of Vivacitas at the value of $1.00 per share shall be $120,000 to be paid in twelve (12) equal monthly installments for the period between April 1, 2021 and March 31, 2022
Share Price		$ 1.00
Vivacitas Oncology Inc [Member] | Common Stock [Member]
Options to purchase additional shares					500,000